Patents by Inventor Carolyn M. Ecelbarger

Carolyn M. Ecelbarger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10107795
    Abstract: Blunting the activity of the P2Y2 receptor results in a resistance to diet-induced obesity, an increased metabolic rate, and a better glucose tolerance. Compounds that inhibit the puringeric P2Y2 receptor are useful for treating disorders associated with diabetes, treating obesity, and increasing metabolism (e.g., fatty acid metabolism).
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: October 23, 2018
    Assignee: The United States of America as represented by the Department of Veterans Affairs
    Inventors: Bellamkonda K. Kishore, Yue Zhang, Carolyn M. Ecelbarger
  • Patent number: 10024846
    Abstract: The invention provides a method for treating or preventing diet-induced obesity in a subject comprising administering an agent in an effective amount so that expression or activity of the P2Y2 receptor is decreased or inhibited in the subject thereby treating or preventing diet-induced obesity in the subject.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: July 17, 2018
    Assignee: The United States of America as represented by the Department of Veterans Affairs
    Inventors: Bellamkonda K. Kishore, Yue Zhang, Carolyn M. Ecelbarger
  • Publication number: 20160377598
    Abstract: The invention provides a method for treating or preventing diet-induced obesity in a subject comprising administering an agent in an effective amount so that expression or activity of the P2Y2 receptor is decreased or inhibited in the subject thereby treating or preventing diet-induced obesity in the subject.
    Type: Application
    Filed: April 27, 2015
    Publication date: December 29, 2016
    Inventors: Bellamkonda K. Kishore, Yue Zhang, Carolyn M. Ecelbarger
  • Publication number: 20150259692
    Abstract: Blunting the activity of the P2Y2 receptor results in a resistance to diet-induced obesity, an increased metabolic rate, and a better glucose tolerance. Compounds that inhibit the puringeric P2Y2 receptor are useful for treating disorders associated with diabetes, treating obesity, and increasing metabolism (e.g., fatty acid metabolism).
    Type: Application
    Filed: October 25, 2013
    Publication date: September 17, 2015
    Inventors: Bellamkonda K. Kishore, Yue Zhang, Carolyn M. Ecelbarger